PA Ubel, RA Hirth, ME Chernew, AM Fendrick - Archives of Internal Medicine, 2003 - Am Med Assoc In each of the 3 articles noted above, the authors made prominent mention of a
threshold by which cost-effectiveness experts judge the affordability of health
care services: those interventions that produce a QALY for $50 000 or less ... Cited by 235 - Related articles - BL Direct - All 5 versions
M Kubin, G Wagner, AR Fugl-Meyer - International journal of impotence research, 2003 - nature.com This review of the current epidemiological literature on erectile dysfunction
(ED) suggests that approximately 5–20% of men have moderate-to-severe ED.
Different definitions of ED, age distributions and concomitant medical ... Cited by 136 - Related articles - BL Direct - All 4 versions
G De Berardis, M Franciosi, M Belfiglio, B Di … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—Overall, 34% of the patients reported frequent erectile problems, 24%
reported occasional problems, and 42% reported no erectile problems. After
adjusting for patient characteristics, erectile dysfunction was associated ... Cited by 111 - Related articles - BL Direct - All 5 versions
- ►onlinejacc.org PA Heidenreich, MA Gubens, GC Fonarow, … - Journal of the American College of Cardiology, 2004 - Elsevier We used a decision model to estimate economic and health outcomes for different
screening strategies using BNP and echocardiography to detect left ventricular
EF <40% for men and women age 60 years. We used published data from ... Cited by 99 - Related articles - BL Direct - All 19 versions
NM Paige, RD Hays, MS Litwin, J Rajfer, MF … - The Journal of urology, 2001 - Elsevier Letters were mailed to eligible patients at a university hospital urology and
internal medicine clinic, and university affiliated community primary care
clinics by the primary care provider or urologist inviting them to ... Cited by 56 - Related articles - BL Direct - All 17 versions
EG Boyce, EM Umland - Clinical therapeutics, 2001 - Elsevier Background: Since its approval by the US Food and Drug Administration in March
1998, sildenafil citrate has been used by millions of men for the treatment of
erectile dysfunction. Recent studies and consensus reports have expanded ... Cited by 54 - Related articles - BL Direct - All 4 versions
M McGregor - Canadian Medical Association Journal, 2003 - canadianmedicaljournal.ca Is it cost-effective? This question is increasingly asked about health
interventions as we attempt to achieve the maximum benefit from limited health
care resources. As a result, cost–effectiveness analysis, which attempts ... Cited by 30 - Related articles - BL Direct - All 12 versions
SB Zeliadt, RD Etzioni, DF Penson, IM … - The American journal of medicine, 2005 - Elsevier Finasteride is associated with a gain of 6 life-years per 1000 men treated at an
incremental cost of $1 660 000 per life-year gained. The quality-adjusted
analysis results in 46 QALYs gained per 1000 men treated at an incremental ... Cited by 32 - Related articles - All 15 versions
A Hollis - Retrieved Dec, 2004 - who.int Abstract Because pharmaceutical markets are dysfunctional, the patent system
does not effectively stimulate drug research and development. Instead, it
induces large amounts of research into drugs with little incremental ... Cited by 24 - Related articles - View as HTML - All 14 versions
